Approval · Notice of Compliance 22157 · 2019
JAMP-FINASTERIDE: Notice of Compliance 22157
Issued May 16, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22157
- Date
- May 16, 2019
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to product mmonograph
- Canadian reference product
- PROSCAR
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP-FINASTERIDE | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB